Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00229450
Status:
COMPLETED
Last Update Posted:
2020-02-25
First Post:
2005-09-28
Brief Title:
Estrogen and Perimenopausal Depression
Sponsor:
University of California Los Angeles
Organization:
University of California Los Angeles
Study Overview
Official Title:
Dose Response Effects of Estrogen Augmentation in Mood Memory in Perimenopausal Depression
Status:
COMPLETED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
During perimenopause the time just prior to menopause women often notice many biological psychological and social changes In particular some women experience depressive symptoms during perimenopause that are severe enough to warrant antidepressant medication Whether or not women with perimenopausal depression respond to antidepressant medication may depend on the level of estrogen in their blood This study will investigate whether estrogen will help women who only partially respond to antidepressant medications as well as examine how different doses of estrogen may affect individuals differently
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 04-05-088 | None | None | None |
| 06806-001 | None | None | None |